News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,817 Results
Type
Article (8036)
Company Profile (140)
Press Release (477640)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166745)
Career Advice (305)
Deals (25738)
Drug Delivery (7)
Drug Development (52876)
Employer Resources (14)
FDA (9760)
Job Trends (8574)
News (238191)
Policy (17906)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (488)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33154)
ALS (106)
Alzheimer's disease (984)
Antibody-drug conjugate (ADC) (279)
Approvals (10398)
Artificial intelligence (327)
ASCO (159)
Autoimmune disease (216)
Automation (29)
Bankruptcy (263)
Best Places to Work (6958)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (30)
Breast cancer (516)
Cancer (3727)
Cardiovascular disease (225)
Career advice (245)
Career pathing (1)
CAR-T (177)
CDMO (11)
Celiac Disease (1)
Cell therapy (483)
Cervical cancer (35)
Clinical research (47992)
Collaboration (1270)
Commercialization (3)
Compensation (1523)
Complete response letters (34)
COVID-19 (758)
CRISPR (64)
C-suite (790)
Cystic fibrosis (86)
Data (5812)
Denatured (4)
Depression (103)
Dermatology (67)
Diabetes (350)
Diagnostics (4202)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73743)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88052)
Executive appointments (710)
FDA (12453)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (937)
Gene editing (126)
Generative AI (9)
Gene therapy (329)
GLP-1 (294)
Government (946)
Grass and pollen (2)
Guidances (281)
Healthcare (9367)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (159)
Infectious disease (948)
Inflammatory bowel disease (127)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (259)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (16)
Liver cancer (45)
Longevity (19)
Lung cancer (527)
Lymphoma (257)
Machine learning (27)
Management (3)
Manufacturing (556)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8675)
Medtech (8830)
Mergers & acquisitions (14403)
Metabolic disorders (719)
mRNA (60)
Multiple sclerosis (106)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (40)
Neuroscience (1853)
NextGen: Class of 2026 (3150)
Non-profit (843)
Obesity (228)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (204)
Parkinson's disease (204)
Partnered (12)
Patents (490)
Patient recruitment (523)
Patient selection (1)
Peanut (31)
People (41323)
Peptides (1)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15503)
Phase 2 (21425)
Phase 3 (14452)
Pipeline (7608)
Policy (18)
Postmarket research (1570)
Preclinical (6550)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (584)
Real estate (3022)
Recruiting (6)
Regulatory (14908)
Reports (23)
Research institute (584)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (158)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (51)
Vaccines (332)
Venture capital (17)
Weight loss (74)
Women's health (83)
Date
Today (22)
Last 7 days (375)
Last 30 days (1285)
Last 365 days (19032)
2026 (13360)
2025 (19251)
2024 (22986)
2023 (26538)
2022 (34592)
2021 (37176)
2020 (33468)
2019 (23256)
2018 (17493)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (228)
Alabama (76)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (17942)
Australia (2106)
California (12276)
Canada (3217)
China (540)
Colorado (491)
Connecticut (424)
Delaware (211)
Europe (24677)
Florida (1841)
Georgia (391)
Hawaii (3)
Idaho (46)
Illinois (721)
India (52)
Indiana (321)
Iowa (16)
Japan (416)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1224)
Massachusetts (8058)
Michigan (312)
Minnesota (568)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (119)
New Hampshire (60)
New Jersey (2679)
New Mexico (12)
New York (2881)
North Carolina (1311)
North Dakota (4)
Northern California (6170)
Ohio (288)
Oklahoma (14)
Oregon (16)
Pennsylvania (2289)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5107)
Tennessee (122)
Texas (1990)
United States (39795)
Utah (367)
Vermont (1)
Virginia (156)
Washington D.C. (38)
Washington State (955)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,817 Results for "fziomed inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fziomed Announces Clinical Results from Level I Study Evaluating Oxiplex Absorbable Gel for Spine Surgery
March 10, 2026
·
3 min read
Press Releases
Fziomed Gains FDA De Novo Classification Grant and Marketing Authorization for Oxiplex® Gel in Spine Surgery
July 9, 2025
·
3 min read
Biotech Beach
FzioMed, Inc. to Showcase its Women’s Health Adhesion Barrier Products at Hysteroscopy, Assisted Reproductive Technology and Ultrasound (HARTUS) Congress
FzioMed, Inc., a recognized global leader in adhesion prevention, announced it will attend the Hysteroscopy, Assisted Reproductive Technology and Ultrasound congress April 22-24 in Rome, Italy.
April 16, 2024
·
4 min read
Press Releases
FzioMed, Inc. to Highlight its Adhesion Barrier Product Solutions at the European Society for Gynecological Endoscopy (ESGE) Congress
October 16, 2024
·
3 min read
Business
FzioMed Announces Addition of Industry Veteran to its Board of Directors
FzioMed, Inc., a global leading surgical biomaterials company focused on spine, orthopedic, peritoneal and gynecological surgery, announced the appointment of industry veteran Alex DiNello to its Board of Directors whose appointment became effective May 1, 2023.
May 17, 2023
·
3 min read
Business
FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO
FzioMed, Inc., a global leading surgical biomaterials company focused on spine/orthopedic, peritoneal and gynecological surgery, announced the appointment of industry veteran Paul Mraz as its new President and CEO and member of the Board of Directors.
January 3, 2023
·
3 min read
Biotech Beach
FzioMed Announces 600,000 Units Of Oxiplex® Shipped Worldwide
FzioMed, Inc., a leading biomaterials company, is pleased to announce that Oxiplex shipments have now passed the 600,000 unit mark.
October 28, 2020
·
1 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Carlsmed, Inc. Announces Chief Operating Officer Appointment
September 8, 2026
·
2 min read
Press Releases
Glucotrack, Inc. Announces Reverse Stock Split
August 27, 2026
·
6 min read
1 of 48,582
Next
